Head & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.

Medicina Oral Patologia Oral y Cirugia Bucal, published by MEDICINA ORAL S L, is a premier journal that caters to the fields of dentistry, medicine, otorhinolaryngology, and surgery. With its ISSN 1698-6946, this esteemed publication has made significant strides in disseminating high-quality research since its inception in 2004, continuing to contribute to the body of knowledge through 2024. Recognized for its impactful contributions, the journal proudly holds a Q1 ranking in Dentistry and significant Q2 rankings in Medicine and Otorhinolaryngology categories for the year 2023. Its impressive Scopus rankings position it among the top journals, with a notable 80th percentile for Medicine & Surgery and Otorhinolaryngology. The journal aims to bridge the gap between academic research and practical application, serving as an essential resource for researchers, healthcare professionals, and students alike. This commitment to excellence ensures that Medicina Oral Patologia Oral y Cirugia Bucal remains a vital platform for the advancement of clinical practices and innovations within its diverse scope.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, published by BMJ PUBLISHING GROUP, is a leading interdisciplinary journal focused on advancing research and clinical practice in the field of gynecological oncology. With an ISSN of 1048-891X and an E-ISSN of 1525-1438, the journal has established itself as a vital resource since its inception in 1991, covering cutting-edge advancements through 2024 and beyond. The journal holds esteemed rankings, including Q1 in Obstetrics and Gynecology and Q2 in Oncology, highlighting its influence and high citation impact within the medical community. Its Scopus rankings underscore its prominence, placing it among the top 13% of journals in Obstetrics and Gynecology and the top 27% in Oncology. Although it does not currently offer Open Access options, the journal provides a platform for researchers, clinicians, and students to share significant findings and developments that shape the future of gynecological cancer research and treatment. The INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER stands as a significant pillar in the ongoing effort to improve patient outcomes and foster innovation in this critical area of healthcare.

BMC CANCER is a prestigious, peer-reviewed journal dedicated to advancing the field of cancer research and oncology since its inception in 2001. Published by BMC, a leading name in open-access publishing, this journal plays a crucial role in providing researchers, professionals, and students with a platform for high-quality scientific discourse. With an impressive impact factor, BMC CANCER is ranked in the Q2 quartile across multiple categories, including Cancer Research, Genetics, and Oncology, reflecting its commitment to impactful research and rigorous peer-review standards. The journal ensures broad accessibility to its content through its Open Access model, allowing findings to reach a global audience without financial barriers. The editorial board consists of recognized experts committed to fostering innovation and collaboration within the cancer research community. Researchers working at the intersection of cancer biology, treatment options, and genetic influences will find BMC CANCER an invaluable resource for sharing their findings and engaging with the latest developments in the field.

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

Clinical Oral Investigations is a premier journal published by SPRINGER HEIDELBERG, specializing in the multifaceted field of dentistry. Established in 1997, this journal serves as an essential resource for researchers, practitioners, and students alike, offering a platform for the dissemination of high-quality peer-reviewed studies that advance the understanding of oral health and its clinical implications. With an impressive impact factor and ranked in the Q1 category for Dentistry, it occupies a distinguished position among the top-tier publications, reflecting its commitment to excellence as evidenced by a Scopus Rank of #14 out of 132 in General Dentistry, placing it in the 89th percentile. While the journal offers a subscription-based model, it continues to make significant contributions to the field through innovative research articles, reviews, and clinical reports. Located in Heidelberg, Germany, Clinical Oral Investigations is a vital resource for those dedicated to the improvement of oral health and dental practices worldwide.

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.

Oral Science International is a distinguished academic journal published by WILEY, focusing on the multidisciplinary field of otorhinolaryngology. With an ISSN of 1348-8643 and an E-ISSN of 1881-4204, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and innovations in oral and maxillofacial sciences. Established over two decades ago, it has steadily built a solid reputation within the scientific community, currently holding a Q3 ranking in the 2023 Otorhinolaryngology category and ranking #77 out of 123 on the Scopus scale, placing it in the 37th percentile. Although it is not an Open Access journal, Oral Science International continues to provide pivotal insights that drive research and professional practice forward. Located in Japan, this journal emphasizes the importance of global collaboration and knowledge sharing in advancing oral health care and associated disciplines.

The Journal of Head & Neck Physicians and Surgeons, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of oncology, oral surgery, otorhinolaryngology, and surgery. Since its transition to Open Access in 2016, the journal has endeavored to disseminate high-quality research and advancements within these specialized areas, fostering collaboration and knowledge sharing among professionals, researchers, and students. With an ISSN of 2347-8128, this journal has established its presence from India and operates with a commitment to rigorous peer review and academic integrity. Despite its relatively recent standing reflected in a Q4 category across several disciplines as well as modest Scopus rankings, the journal's focus on niche scientific studies provides a platform for impactful research to reach practitioners and scholars globally. Continuously adapting to the evolving landscape of medical science, the Journal of Head & Neck Physicians and Surgeons aims to be an essential publication for those aiming to enhance their understanding and clinical practices related to head and neck conditions.

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.